Stock Screener App

Gratuito -

2.97

3.30% -0.06

Galectin Therapeutics Inc (GALT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Galectin Therapeutics Inc Borsa (GALT) Ultime notizie

Wall Street Breakfast: The Week Ahead

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

The Motley Fool

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

GlobeNewswire Inc.

$81.30

0.33%

$163.15

0.93%

$28.80

0.12%

$152.55

1.33%

$93.41

1.71%

$372.79

0.58%

Apri su Yahoo | Apri su Google | Aperto in Finviz